Early detection of chronic liver disease in primary care: real-world perspectives

Key discussion points:

Why early detection of MASLD/MASH matters and how it can transform patient outcomes.

The readiness of primary care professionals to expand liver disease screening and management.

How innovative tools like AI and predictive analytics can support smarter, more integrated approaches to detection and risk assessment.

What new MASH-focused treatments mean for general practitioners and nurses: awareness, diagnosis, and referral pathways for liver fibrosis.

Who should watch?

Primary care physicians and nurses, patients and their families, patient associations, patient advocates, primary healthcare professionals, nurses, dietitians, gastroenterologists, hepatologists, and anyone interested in learning more about chronic liver disease and how it is managed in primary care.

Moderator:

Prof. Dr Jörn Schattenberg,  Professor of Medicine. Department of Internal Medicine Gastroenterology, Hepatology and Endocrinology, Saarland University Medical Centre, Homburg, Germany. 

Panelists:

• Professor Thomas Frese, President of WONCA Europe and Professor of General Practice at Martin Luther University Halle-Wittenberg. Germany 
• Dr Craig Nicoll, General Practitioner, Springfield West Medical Centre, NHS, Scotland, UK  
• Prof. Dr. Josep M. Vilaseca, Past Treasurer WONCA Europe, Associate Professor at the University of Vic, Central Catalonia University, Spain 

Access

Public

Year

2025